Sotheby’s Reports First Quarter 2017 Financial Results
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Sotheby’s (NYSE:BID) today reported its financial results for the first quarter ended March 31, 2017. For the three months ended March 31, 2017, Sotheby’s reported a net loss of ($11.3)...
Sotheby’s Reports First Quarter 2017 Financial Results
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Sotheby’s (NYSE:BID) today reported its financial results for the first quarter ended March 31, 2017. For the three months ended March 31, 2017, Sotheby’s reported a net loss of ($11.3)...
Anavex Reports Fiscal Second Quarter 2017 Financial Results
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Anavex Reports Fiscal Second Quarter 2017 Financial Results
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Edge Therapeutics to Present at Bank of America Merrill Lynch 2017 Health Care Conference
May 10, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., May 10, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
Ducommun to Present at the B. Riley Investor Conference on May 24
May 10, 2017 11:00 am UTC| Business
LOS ANGELES, May 10, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today announced that it will participate in the 18th Annual B. Riley Co. Investor Conference on May 24, 2017 at the Loews...
Cempra Presents Data on Ophthalmic Solithromycin at ARVO
May 10, 2017 11:00 am UTC| Business
CHAPEL HILL, N.C., May 10, 2017 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...